Update on a Phase 1/2 First-in-Human Study of the Menin-KMT2A (MLL) Inhibitor Ziftomenib (KO-539) in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Author:

Erba Harry P.1,Fathi Amir T.23,Issa Ghayas C.4,Altman Jessica K.5,Montesinos Pau6,Patnaik Mrinal M.7,Foran James M.8,De Botton Stephane9,Baer Maria R.10,Schiller Gary J.11,Walter Roland B.12,Kremyanskaya Marina13,Pettit Kristen M.14,Strickland Stephen A15,Tomkinson Blake16,Tabachri Marilyn16,Leoni Mollie16,Dale Stephen16,Wang Eunice S.17

Affiliation:

1. 1Leukemia Program, Duke University Medical Center, Durham, NC

2. 2Director of Leukemia Program, Massachusetts General Hospital, Boston, MA

3. 3Associate Professor of Medicine, Harvard Medical School, Boston, MA

4. 4Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

5. 5Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL

6. 6Hospital Universitari i Politècnic La Fe, Instituto de Investigación Sanitaria La Fe (IISLAFE), Valencia, Spain

7. 7Division of Hematology, Mayo Clinic, Rochester, MN

8. 8Division of Hematology/Oncology and Blood and Marrow Transplanation and Cellular Therapy, Mayo Clinic, Jacksonville, FL

9. 9Department of Haematology, Institut Gustave Roussy, Villejuif, France

10. 10University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD

11. 11David Geffen School of Medicine at UCLA, Los Angeles, CA

12. 12Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA

13. 13Tisch Cancer Institute, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY

14. 14Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI

15. 15Vanderbilt-Ingram Cancer Center, Nashville, TN

16. 16Kura Oncology, Boston, MA

17. 17Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Cited by 39 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3